Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing biological mechanisms without new human data or systematic methodology.
PubMed 42052154 · doi:10.1007/s44466-026-00040-6
What was done
This narrative review summarizes the biological mechanisms, regulatory layers (including posttranslational modifications, epigenetic reprogramming, metabolic rewiring, and signaling condensates), disease associations, and therapeutic modulation of Toll-like receptors (TLRs) in innate immunity and inflammation.
What was found
The abstract reports no numerical data or quantitative outcomes. It describes the role of TLRs in sensing pathogen-associated and damage-associated molecular patterns, their involvement in diseases ranging from cancer and autoimmunity to neurodegenerative disorders, and the therapeutic potential of TLR agonists and antagonists.
Why it matters
It outlines how fundamental mechanisms of pattern-recognition receptor regulation connect to disease pathogenesis and identifies TLR modulation as an avenue for targeted immunotherapy.
Limits
The paper is a narrative review rather than an empirical study or systematic review, presenting no original clinical data or statistical evidence. The abstract does not report specific pharmacological compounds, clinical trial results, or quantitative metrics.